New regenerative medicines centre and bioincubator opened in Scotland
This article was originally published in Scrip
Research into new therapies for conditions such as multiple sclerosis and heart disease is expected to receive a boost with the official opening on 28 May of the Scottish Centre for Regenerative Medicine and a new 85,000sq ft bioincubator facility at the Edinburgh BioQuarter, a life-science campus located just to the south-east of the Scottish capital.
You may also be interested in...
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national, European and global level.
The EU’s massive economic stimulus package, Next Generation EU, includes a wide-ranging health program that aims to make health systems more resilient to future threats by supporting the development and manufacture of affordable new medicines and vaccines as well as measures to prevent drug shortages.
UK proposals for limited cooperation with the EU in medicines regulation, including the recognition of certificates and inspections, are one glimmer of light in an otherwise uncertain post-Brexit regulatory scenario for the UK. But time pressures and political spats over the future relationship could throw the whole enterprise into doubt.